Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

E. Bloomfield, Hanna; J. Robins, Sander; Collins, Dorothea; L. Fye, Carol; W. Anderson, James; B. Elam, Marshall; H. Faas, Fred; Linares, Esteban; J. Schaefer, Ernst; Schectman, Gordon; J Wilt, Timothy; Wittes, Janet

doi:10.1056/nejm199908053410604

Public

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Published in New England Journal of Medicine • Aug 5, 1999

Authors:

Hanna E. Bloomfield

Sander J. Robins

Dorothea Collins

Abstract

BACKGROUND: Although it is generally accepted that lowering elevated serum levels of low-density lipoprotein (LDL) cholesterol in patients with coronary heart disease is beneficial, there are few data to guide decisions about therapy for patients whose primary lipid abnormality is a low level of hig...

Subject

Gemfibrozil

Medicine

Myocardial infarction

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!